Aligos Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid
Aligos Therapeutics, Inc. (ALGS) had Lessee, Operating Lease, Liability, to be Paid of $5.42 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-03-05
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $5.42M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $9.05M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $12.65M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $14.85M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-12-31 | $5.42M 10-K · filed 2026-03-05 |
| 2024-12-31 | $9.05M 10-K · filed 2025-03-10 |
| 2023-12-31 | $12.65M 10-K · filed 2024-03-12 |
| 2022-12-31 | $14.85M 10-K · filed 2023-03-09 |
| 2021-12-31 | $17.85M 10-K · filed 2022-03-10 |
| 2020-12-31 | $17.10M 10-K · filed 2021-03-23 |
| 2020-09-30 | $17.73M 10-Q · filed 2020-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |